Bile acid structure and selective modulation of murine hepatic cytochrome P450-linked enzymes

Hepatology

Volumn 30, Issue 3, 1999, Pages 730-739

  Paolini, Moreno ^a   Pozzetti, Laura ^a   Piazza, Francesco ^a   Cantelli Forti, Giorgio ^a   Roda, Aldo ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; CYTOCHROME P450 ISOENZYME; DIMETHYLNITROSAMINE DEMETHYLASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; TAURODEOXYCHOLIC ACID; TAUROURSODEOXYCHOLIC ACID;

ANIMAL EXPERIMENT; ARTICLE; BILE; ELECTROPHORESIS; ENZYME ACTIVITY; ENZYME INDUCTION; LIVER METABOLISM; LIVER MICROSOME; MALE; MOUSE; NONHUMAN; NORTHERN BLOTTING; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; WESTERN BLOTTING;

ANIMALS; ARYL HYDROCARBON HYDROXYLASES; BILE ACIDS AND SALTS; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME INDUCTION; LIVER; MALE; MICE; STEROID 16-ALPHA-HYDROXYLASE; TAURODEOXYCHOLIC ACID; URSODEOXYCHOLIC ACID;

EID: 0032843793     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510300332     Document Type: Article

References (26)

1. McLuen EF, Fouts JR. The effect of obstructive jaundice on drug metabolism in rabbits. J Pharmacol Exp Ther 1961;131:1-7.
2. Denk H, Greim H, Hutterer F, Schaffner F, Popper H. Turnover of hepatic cytochrome P450 in experimental cholestasis. Exp Mol Pathol 1973;19: 241-247.
3. Hutterer F, Denk H, Bacchin PG, Schenkman JB, Schaffner F, Popper H. Mechanism of cholestasis. 1. Effect of bile acids on microsomal cytochrome P450-dependent biotransformation system in vivo. Life Sci 1970;9:877-887.
4. Hutterer F, Denk H, Bacchin PG, Schenkman JB, Schaffner F, Popper H. Mechanism of cholestasis. 2. Effect of bile acids on microsomal cytochrome P450-dependent biotransformation system in vivo. Life Sci 1970;9:1159-1166.
5. Mackinnon AM, Simon FR. Reduced synthesis of hepatic microsomal cytochrome P450 in the bile duct ligated rats. Biochem Biophys Res Commun 1974;56:437-443.
6. Chen J, Farrell GC. Bile acids produce a generalized reduction of the catalytic activity of cytochromes P450 and other hepatic microsomal enzymes in vitro: relevance to drug metabolism in experimental cholestasis. J Gastoenterol Hepatol 1996;11:870-877.
7. Chen J, Murray M, Jiang X-M, Liddle C, Farrell GC. Down-regulation of male-specific cytochrome P450s 2C11 and 3A2 in bile duct-ligated male rats; importance to reduced hepatic content of cytochrome P450 cholestasis. HEPATOLOGY 1995;22:580-587.
8. Schaffner F, Bacchin PG, Hutterer E Mechanism of cholestasis. 4. Structural and biochemical changes in the liver and serum in rats after bile duct-ligation. Gastroenterology 1971;60:888-897.
9. Kitani K, Kanai S, Ohta M, Tsukahara K. Ursodeoxycholate (UDC) prevents the hepatocellular damage caused by other bile salts as its conjugates in rats. HEPATOLOGY 1988;8:1456-1460.
10. Kitani K, Ohta M, Kanai S. Tauroursodeoxycholate prevents biliary protein excretion induced by other bile salts in the rat. Am J Physiol 1985;248:G407-G417.
11. Roda A, Piazza F, Baraldini M, Speroni E, Guerra MC, Cerrè C, Cantelli-Forti G. Taurohyodeoxycholic acid protects against taurochenodeoxycholic acid-induced cholestasis in the rat. HEPATOLOGY 1998;27: 520-525.
12. Kitani K, Kanai S, Sato Y, Ohta M. Tauro α-muricholate is as effective as Tauro β-muricholate and tauroursodeoxycholate in preventing the hepatocyte damage caused by continuous infusion of taurochenodeoxycholate in the rat. HEPATOLOGY 1994;19:1011-1012.
13. Kitani K, Kanai S, Ohta M. The preventive effects of glycine conjugates of Ursodeoxycholate, β;-muricholate on taurochenodeoxycholate induced cholestasis in the rat. Acta Hepatol Jpn 1993;34(Suppl):247.
14. Kanai S, Ohta M, Kitani K, Sato Y. Tauro β-muricholate is as effective as tauroursodeoxycholate in preventing taurochenodeoxycholate-induced liver damage in the rat. Life Sci 1990;47:2421-2428.
15. Roda A, Cerré C, Manetta AC, Cainelli G, Umani-Ronchi A, Panunzio M. Synthesis and physicochemical, biological and pharmacological properties of new bile acids amidated with cyclic amino acids. J Med Chem 1996;39:2270-2276.
16. Roda A, Pellicciari R, Polimeni C, Cerré C, Cantelli Forti G, Sadeghpour B, Sapigni E, et al. Metabolism, pharmacokinetics, and activity of a new 6-fluoro analogue of ursodeoxycholic acid in rats and hamsters. Gastroenterology 1995;108:1204-1214.
17. Ward A, Brogden AN, Heel RC, Speight TM, Avery GS. Ursodeoxycholic acid: a review of its pharmacological properties and therapeutic efficacy. Drugs 1984;27:95-131.
18. Kaplan MM, Righetti A. Induction of rat liver alkaline phosphatase: the mechanism of the serum elevation in bile duct obstruction. J Clin Invest 1970;49:508-516.
19. Kaplan MM, Onkubo A, Quaroni EG, Sze-Tu D. Increased synthesis of rat liver alkaline phosphatase by bile duct ligation. HEPATOLOGY 1983;3: 433-439.
20. Gurantz D, Schteingart CD, Hagey LR, Steinbach JH, Grotmol T, Hofmann AF. Hypercholeresis induced by unconjugated bile acids infusion correlates with recovery in bile of unconjugated bile acids. HEPATOLOGY 1991;13:340-550.
21. Gerloff T, Stieget B, Hagenbuch B, Madon J, Landmann L, Roth J, Hofmann AF, et al. The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver. J Biol Chem 1998;273:10046-10050.
22. Salphati L, Bernet LZ. Modulation of P-glycoprotein expression by cytochrome P450 inducers in male and female rat livers. Biochemical Pharmacol 1998;55:387-395.
23. Accatino L, Pizarro M, Solis N, Koenig CS, Vollrath V, Chianale J. Modulation of hepatic content and biliary excretion of P-glycoprotein in hepatocellular and obstructive cholestasis in rat. J Hepatol 1996;25:349-361.
24. Poupon RE, Poupon R, Balkau B. Ursodiol for the long-term treatment of primary biliary cirrhosis. N Engl J Med 1994;330:1342-1347.
25. Loria P, Bozzoli M, Angelico M, Bertolotti M, Carubbi F, Concari M, Baiochi L, et al. Effect of taurohyodeoxycholic acid on biliary lipid secretion in man; preliminary report. Ital J Gastroenterol 1996;28:391-392.
26. Paolini M, Mesirca R, Pozzetti L, Sapone A, Cantelli-Forti G. Induction of CYP 2B1 mediated pemoxyresorufin O-dealkylase activity in different species, sex and tissue by prototype 2B1-inducers. Chem Biol Interact 1995;95:127-139.